Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 10-1997 | 07-1997 | 04-1997 | |
| Sales | 31,448 | 39,310 | 14,549 | 19,450 | 15,737 |
| Cost of Goods | 30,835 | 37,689 | 13,272 | 17,781 | 14,521 |
| Gross Profit | 613 | 1,620 | 1,278 | 1,669 | 1,216 |
| Operating Expenses | 476 | 423 | 994 | 1,016 | 930 |
| Operating Income | 136 | 1,198 | 284 | 653 | 286 |
| Other Income | -136 | 493 | 0 | 73 | 930 |
| Pre-tax Income | N/A | 1,691 | 284 | 726 | 1,216 |
| Income Tax | 204 | 493 | 213 | 290 | 215 |
| Net Income Continuous | N/A | 1,198 | 71 | 435 | 1,001 |
| Minority Interests | 68 | -70 | N/A | N/A | N/A |
| Net Income | $N/A | $1,198 | $71 | $435 | $1,001 |
| EPS Basic Total Ops | N/A | 0.13 | 0.01 | 0.06 | 0.15 |
| EPS Basic Continuous Ops | N/A | 0.13 | 0.01 | 0.06 | 0.15 |
| EPS Diluted Total Ops | N/A | 0.13 | 0.01 | 0.06 | 0.15 |
| EPS Diluted Continuous Ops | N/A | 0.13 | 0.01 | 0.06 | 0.15 |
| EBITDA(a) | $613 | $1,620 | $497 | $728 | $429 |